CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers

Translational Research

Volumn 165, Issue 6, 2015, Pages 717-730

  Fridrichova, Ivana ^a   Smolkova, Bozena ^b   Kajabova, Viera ^b   Zmetakova, Iveta ^b   Krivulcik, Tomas ^b   Mego, Michal ^b   Cierna, Zuzana ^b   Karaba, Marian ^b   Benca, Juraj ^b   Pindak, Daniel ^b   Bohac, Martin ^b   Repiska, Vanda ^b   Danihel, Ludovit ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM23 PROTEIN; DNA; RAS PROTEIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; ADAM23 PROTEIN, HUMAN; CXCL12 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL GROWTH; COLON POLYPOSIS; DISEASE ASSOCIATION; DNA METHYLATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYROSEQUENCING; TRANSCRIPTION INITIATION; BREAST TUMOR; GENETICS; METABOLISM; PATHOLOGY;

ADAM PROTEINS; BREAST NEOPLASMS; CHEMOKINE CXCL12; DNA METHYLATION; FEMALE; HUMANS; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84928966270     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2014.12.006     Document Type: Article

References (55)

1. J. Ferlay, E. Steliarova-Foucher, and J. Lortet-Tieulent Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 Eur J Cancer 49 2013 1374 1403
2. J. Barinoff, R. Hils, and A. Bender Clinicopathological differences between breast cancer in patients with primary metastatic disease and those without: a multicentre study Eur J Cancer 49 2012 305 311
3. C.A. Klein Cancer. The metastasis cascade Science 321 2008 1785 1787
4. N. Suzuki, A. Kamataki, J. Yamaki, and Y. Homma Characterization of circulating DNA in healthy human plasma Clin Chim Acta 387 2008 55 58
5. A. Ziegler, U. Zangemeister-Wittke, and R.A. Stahel Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev 28 2002 255 271
6. S. Jahr, H. Hentze, and S. Englisch DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells Cancer Res 61 2001 1659 1665
7. K. Jung, M. Fleischhacker, and A. Rabien Cell-free DNA in the blood as a solid tumor biomarker - a critical appraisal of the literature Clin Chim Acta 411 2010 21 22
8. J.A. Joyce, and J.W. Pollard Microenvironmental regulation of metastasis Nat Rev Cancer 9 2009 239 252
9. P.A. Jones, and S.B. Baylin The fundamental role of epigenetic events in cancer Nat Rev Genet 3 2002 415 428
10. R. Dammann, U. Schagdarsurengin, and C. Seidel The tumor suppressor RASSF1A in human carcinogenesis: an update Histol Histopathol 20 2005 645 663
11. L. Pasquali, A. Bedeir, S. Ringquist, A. Styche, R. Bhargava, and G. Trucco Quantification of CpG island methylation in progressive breast lesions from normal to invasive carcinoma Cancer Lett 257 2007 136 144
12. I. Van der Auwera, S.J. Van Laere, and S.M. Van den Bosch Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype Br J Cancer 99 2008 1735 1742
13. A. Dallol, A. Agathanggelou, and S.L. Fenton RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics Cancer Res 64 2004 4112 4116
14. M. Jönsson, A. Borg, M. Nilbert, and T. Andersson Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling in human breast cancer Eur J Cancer 36 2000 242 248
15. K.D. Sutherland, G.J. Lindeman, and D.Y. Choong Differential hypermethylation of SOCS genes in ovarian and breast carcinomas Oncogene 23 2004 7726 7733
16. R. Rottapel, S. Ilangumaran, and C. Neale The tumor suppressor activity of SOCS-1 Oncogene 21 2002 4351 4362
17. Y. Yuan, R. Mendez, A. Sahin, and J.L. Dai Hypermethylation leads to silencing of the SYK gene in human breast cancer Cancer Res 61 2001 5558 5561
18. M. Widschwendter, K.D. Siegmund, and H.M. Müller Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen Cancer Res 64 2004 3807 3813
19. P.J. Coopman, and S.C. Mueller The Syk tyrosine kinase: a new negative regulator in tumor growth and progression Cancer Lett 241 2006 159 173
20. D. Zou, H.S. Yoon, D. Perez, R.J. Weeks, P. Guilford, and B. Humar Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia J Pathol 218 2009 265 272
21. N.V. Verbisck, E.T. Costa, and F.F. Costa ADAM23 negatively modulates alpha(v)beta(3) integrin activation during metastasis Cancer Res 69 2009 5546 5552
22. F.F. Costa, N.V. Verbisck, and A.C. Salim Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors Oncogene 23 2004 1481 1488
23. E.A. Ramos, A.A. Camargo, and K. Braun Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer BMC Cancer 10 2010 23
24. W. Zhou, Z. Jiang, and N. Liu Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas J Cancer Res Clin Oncol 135 2009 91 102
25. K.E. Bachman, J.G. Herman, and P.G. Corn Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers Cancer Res 59 1999 798 802
26. E.L. Lui, W.T. Loo, L. Zhu, M.N. Cheung, and L.W. Chow DNA hypermethylation of TIMP3 gene in invasive breast ductal carcinoma Biomed Pharmacother 59 Suppl 2 2005 363 365
27. M.J. Seraj, R.S. Samant, M.F. Verderame, and D.R. Welch Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13 Cancer Res 60 2000 2764 2769
28. B.J. Metge, A.R. Frost, and J.A. King Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer Clin Exp Metastasis 25 2008 753 763
29. E.K. Keeton, and M. Brown Coregulator expression and breast cancer: improving the predictive power of estrogen receptor alpha Clin Cancer Res 9 2003 1229 1230
30. C.R. Hagan, and C.A. Lange Molecular determinants of context-dependent progesterone receptor action in breast cancer BMC Med 12 2014 32
31. P. Parrella, M.L. Poeta, and A.P. Gallo Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors Clin Cancer Res 10 2004 5349 5354
32. R.G. Lapidus, A.T. Ferguson, and Y.L. Ottaviano Methylation of estrogen and progesterone receptor gene 5′ CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors Clin Cancer Res 2 1996 805 810
33. K.P. Suijkerbuijk, M.J. Fackler, and S. Sukumar Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer Ann Oncol 19 2008 1870 1874
34. J.S. Lee, M.J. Fackler, and J.H. Lee Basal-like breast cancer displays distinct patterns of promoter methylation Cancer Biol Ther 9 2010 1017 1024
35. I. Zmetakova, L. Danihel, and B. Smolkova Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer Neoplasma 60 2013 635 646
36. W. Feng, R. Orlandi, and N. Zhao Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers BMC Cancer 10 2010 378
37. A.A. Muggerud, J.A. Rønneberg, and F. Wärnberg Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer Breast Cancer Res 12 2010 R3
38. W. Remmele, and K.M. Schicketanz Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS) Pathol Res Pract 189 1993 862 866
39. K. Sebova, I. Zmetakova, and V. Bella RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer Cancer Biomark 10 2011-2012 13 26
40. V. Kajabova, B. Smolkova, and I. Zmetakova RASSF1A promoter methylation levels positively correlate with estrogen receptor expression in breast cancer patients Transl Oncol 6 2013 297 304
41. Y.H. Cho, H. Yazici, and H.C. Wu Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients Anticancer Res 30 2010 2489 2496
42. A. Buhmeida, A. Merdad, and J. Al-Maghrabi RASSF1A methylation is predictive of poor prognosis in female breast cancer in a background of overall low methylation frequency Anticancer Res 31 2011 2975 2981
43. S.R. Sturgeon, R. Balasubramanian, C. Schairer, H.B. Muss, R.G. Ziegler, and K.F. Arcaro Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls Epigenetics 7 2012 1258 1267
44. L.D. Hoefnagel, M.J. van de Vijver, and H.J. van Slooten Receptor conversion in distant breast cancer metastases Breast Cancer Res 12 2010 R75
45. L.S. Lindström, E. Karlsson, and U.M. Wilking Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression J Clin Oncol 30 2012 2601 2608
46. W. Feng, L. Shen, and S. Wen Correlation between CpG methylation profiles and hormone receptor status in breast cancers Breast Cancer Res 9 2007 R57
47. E. Hervouet, P.F. Cartron, M. Jouvenot, and R. Delage-Mourroux Epigenetic regulation of estrogen signaling in breast cancer Epigenetics 8 2013 237 245
48. L. Li, K.M. Lee, and W. Han Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer Hum Mol Genet 19 2010 4273 4277
49. S. Thaler, M. Schmidt, A. Schad, and J.P. Sleeman RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development Oncogene 31 2012 4912 4922
50. S.Y. Park, H.J. Kwon, and H.E. Lee Promoter CpG island hypermethylation during breast cancer progression Virchows Arch 458 2011 73 84
51. Z. Barekati, R. Radpour, and Q. Lu Methylation signature of lymph node metastases in breast cancer patients BMC Cancer 12 2012 244
52. B. Felding-Habermann, T.E. O'Toole, and J.W. Smith Integrin activation controls metastasis in human breast cancer Proc Natl Acad Sci U S A 98 2001 1853 1858
53. M. Allinen, R. Beroukhim, and L. Cai Molecular characterization of the tumor microenvironment in breast cancer Cancer Cell 6 2004 17 32
54. E.A. Ramos, M. Grochoski, and K. Braun-Prado Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer PLoS One 6 2011 e29461
55. A. Müller, B. Homey, and H. Soto Involvement of chemokine receptors in breast cancer metastasis Nature 410 2001 50 56